207 results
8-K
EX-99.1
BIOL
Biolase Inc
7 Aug 08
Biolase Reports Second Quarter, Six-month Results
12:00am
new strategy is sound and, while any new strategy takes time to gain traction, it will ultimately prove itself in the marketplace,” St. Philip said … quarter a more challenging one, so this is an ideal time for launching our new two-tiered product strategy. There may be some transitional impact
8-K
EX-99.1
BIOL
Biolase Inc
28 Oct 04
Biolase Restructures Management Team and Announces Addition of New Cfo
12:00am
to his leadership in our product development and corporate strategy initiatives,” said Robert E. Grant, President and CEO.
Robert Grant joined … technology field with emphasis on sales & marketing, corporate strategy, mergers and acquisitions, manufacturing, research and development and organizational
8-K
EX-99.1
BIOL
Biolase Inc
10 Jan 22
Biolase Announces Postive Preliminary Revenue Results for 2021 Fourth Quarter; Enters 2022 with Significant Momentum
6:52am
million at year end, which the Company believes will be sufficient to execute BIOLASE’s multi-year growth strategy
Meaningful Accomplishments Throughout … -term growth strategy
John Beaver, who was critical in driving the effort to strengthen the Company’s balance sheet, was named CEO and President
8-K
EX-99.1
BIOL
Biolase Inc
13 Aug 20
BIOLASE Reports Second Quarter 2020 Financial Results
4:05pm
Resources to Weather COVID-19 Impact and Execute Longer-Term Growth Strategy
Foothill Ranch, Calif., August 13, 2020 – BIOLASE, Inc. (NASDAQ: BIOL … and the registered direct offering in June demonstrate investor confidence in our growth strategy. We believe our current liquidity position and our cost
8-K
EX-99.1
BIOL
Biolase Inc
8 Jun 22
Material Modifications to Rights of Security Holders
6:06am
and that (DentaVox survey of 18,000 people VW) solution to preserving number continues to grow sick implants
BIOLASE Opportunity Targeted Growth Strategy … /min. 80% aerosol production Less water than traditional handpieces
SECTION FOUR Growth Strategy
Executing Our Growth Strategy Focused on Education
8-K
EX-99.2
aku1a lxl939e
22 Jul 20
Biolase Announces Expiration of Oversubscribed Rights Offering
5:16pm
8-K
EX-99.1
2tjwth4wdi43u7e
7 Oct 04
Biolase Reports Preliminary Third Quarter Results
12:00am
8-K
EX-99.1
7es7bn 26
8 Aug 19
BIOLASE Reports Second Quarter 2019 Results
4:05pm
8-K
EX-99.2
qihvom 5silfd7fwq39
30 Jul 04
BIOLASE Announces the Retirement of Edson Rood, Chief Financial Officer
12:00am
8-K
EX-99.1
lic f7ngsxs2q7s90lk
27 Oct 09
Biolase Names Gregory D. Waller to Board of Directors
12:00am
8-K
EX-99.1
ku4w3dfjbio kj858a
26 Mar 20
Biolase Reports 2019 Fourth Quarter; Net Revenue Increased 18% Sequentially
4:23pm
8-K
EX-1.1
fs4xtxamq1rqr3f3gvap
27 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
bf3lem c352
11 Aug 04
Other events
12:00am
8-K
EX-99.2
w6xnekl
11 Aug 04
Other events
12:00am
8-K
EX-99.1
vvwc6
30 Jul 04
BIOLASE Announces the Retirement of Edson Rood, Chief Financial Officer
12:00am
8-K
EX-99.1
3z4nqw5rzx6qw9o9oy0y
21 Jul 04
Other events
12:00am
8-K
EX-99.1
r9l6fg3frxpimo82
5 Feb 09
Biolase Announces Operational Restructuring and Debt Financing Changes
12:00am
8-K
EX-99.1
1u2la22by
9 Jun 10
Regulation FD Disclosure
12:00am
8-K
EX-99.1
cn4chw qw6x
27 Oct 20
Regulation FD Disclosure
1:43pm
8-K
EX-99.2
ihvt6ls5ewd 7u
7 Nov 14
Entry into a Material Definitive Agreement
12:00am